3B Medical Inc has received FDA 510(k) clearance for its new Luna Positive Airway Pressure (PAP) device platform, according to a company announcement.
Breethe Inc has obtained exclusive rights to develop a wearable, portable blood pump oxygenator that will function as an artificial lung system for patients suffering from cardiopulmonary collapse and respiratory failure.
Canadian researchers have created a portable tool to predict avian flu outbreaks on farms.
Designed and manufactured in the USA, the Drive Pure O2 stationary concentrator is available in both oxygen sensing and non-oxygen sensing units.
Philips Respironics' Pico nasal mask is now available in the United States for the treatment of obstructive sleep apnea (OSA), according to a company announcement.
MedImmune has received fast track designation from the FDA for the development of MEDI8897, which is being investigated for use in infants and young children with RSV.
A Lung Disease News report discusses the new wearable devices designed to help manage cardiovascular and respiratory diseases.
The FDA has released enhanced recommendations on the production and disinfection of reusable medical devices, according to a press release.
GlaxoSmithKline has received approval from the Japanese Ministry of Health, Labour and Welfare for Encruse Ellipta to treat COPD. The drug has already been approved in the US and Canada under the trade name Incruse Ellipta.
Nihon Kohden has procured a group purchasing agreement for physiological monitoring with Premier Inc, a leading healthcare improvement company representing 3,400 US hospitals and 110,000 other providers.
The Portex Blue Line Ultra tracheostomy tubes with thin-walled inner cannulae allow increased respiratory airflow and help improve the patient’s work of breathing while maintaining patency and airway hygiene.
Two FDA advisory committees have voted 16 to 4 in favor of approving Breo Ellipta for the treatment of asthma in adults aged 18 years and older.
Last fall, GE Healthcare released its newest critical care ventilator to European markets, the Carescape R860. The ventilator uses advanced lung protection tools and an intuitive touchscreen interface to help improve patient care.
Breo Ellipta, a respiratory medicine for COPD, failed to show any safety concerns when used to treat asthma per a preliminary FDA review but faces added scrutiny to assess its safety.
Arch Biopartners has identified a new drug candidate to treat Pseudomonas aeruginosa respiratory infections and intends to move forward with a human trial this year to test its safety.
Merck announced new data evaluating KEYTRUDA, an anti-PD-1 therapy, in advanced non-small cell lung cancer and malignant pleural mesothelioma.
The top ten finalists for the biannual Innovative HME Retail Product Awards have been named, according to a Medtrade news release.
Dieter Kirsch developed a system for his son with cystic fibrosis that analyzes his nebulizer use with a video game.
AstraZenaca's investigational COPD drug PT003 hit its main goals in two late-stage trials, clearing the way for regulatory filings this year in the US and EU.
Mediware's Cardiac and Pulmonary Rehab solution helps support the CMS readmission reduction program, specifically related to COPD.